Sameer Arora
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sameer Arora has a total of 224 co-authors. Here are the top co-authors by number of shared publications:
Arman Qamar
Section of Interventional Cardiology & Vascular Medicine, Division of Cardiology, NorthShore University Health System, Evanston, Illinois, USA
16 shared publications- John P. Vavalle
Division of Cardiology, University of North Carolina School of Medicine, Chapel Hill, North Carolina
15 shared publications - Paula D. Strassle
Department of Epidemiology and Biostatistics, University of Maryland School of Public Health, College Park, USA
14 shared publications John P. Vavalle
Division of Cardiology University of North Carolina Chapel Hill NC
13 shared publications- Michael J. Hendrickson
University of North Carolina Chapel Hill, Chapel Hill, NC
13 shared publications - Arman Qamar
Division of Interventional Cardiology and Vascular Medicine, Endeavor Health (NorthShore University HealthSystem), Glenbrook Hospital, Glenview, IL (A.Q.).
11 shared publications
Latest Publications
- Open Access
- 4 July 2023
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 12 (13) , e027851
Mortality in Patients Hospitalized With Acute Myocardial Infarction Without Standard Modifiable Risk Factors: The ARIC Study Community Surveillance
Background: Prevention strategies targeting standard modifiable cardiovascular risk factors (SMuRFs; diabetes, hypertension, smoking, hypercholesterolemia) are critical to improving cardiovascular disease outcomes. However, acute myocardial infarction (AMI) among individuals who lack 1 or more SMuRFs is not uncommon. Moreover, the clinical characteristics and prognosis of SMuRFless individuals are not well characterized. Methods and Results: We analyzed AMI hospitalizations from 2000 to 2014 captured by the ARIC (Atherosclerosis Risk in Community) study community surveillance. AMI was classified by physician review using a validated algorithm. Clinical data, medications, and procedures were abstracted from the medical record. Main study outcomes included short‐ and long‐term mortality within 28 days and 1 year of AMI hospitalization. Between 2000 and 2014, a total of 742 (3.6%) of 20 569 patients with AMI were identified with no documented SMuRFs. Patients without SMuRFs were less likely to receive aspirin, nonaspirin antiplatelet therapy, or beta blockers and less often underwent angiography and revascularization. Compared with those with one or more SMuRFs, patients without SMuRFs had significantly higher 28‐day (odds ratio, 3.23 [95% CI, 1.78–5.88]) and 1‐year (hazard ratio, 2.09 [95% CI, 1.29–3.37]) adjusted mortality. When examined across 5‐year intervals from 2000 to 2014, the incidence of 28‐day mortality significantly increased for patients without SMuRFs (7% to 15% to 27%), whereas it declined for those with 1 or more SMuRFs (7% to 5% to 5%). Conclusions: Individuals without SMuRFs presenting with AMI have an increased risk of all‐cause mortality with an overall lower prescription rate for guideline‐directed medical therapy. These findings highlight the need for evidence‐based pharmacotherapy during hospitalization and the need to discover new markers and mechanisms for early risk identification in this population.
- 4 July 2023
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 12 (13) , e027851
Open AccessMortality in Patients Hospitalized With Acute Myocardial Infarction Without Standard Modifiable Risk Factors: The ARIC Study Community Surveillance
Background: Prevention strategies targeting standard modifiable cardiovascular risk factors (SMuRFs; diabetes, hypertension, smoking, hypercholesterolemia) are critical to improving cardiovascular disease outcomes. However, acute myocardial infarction (AMI) among individuals who lack 1 or more SMuRFs is not uncommon. Moreover, the clinical characteristics and prognosis of SMuRFless individuals are not well characterized. Methods and Results: We analyzed AMI hospitalizations from 2000 to 2014 captured by the ARIC (Atherosclerosis Risk in Community) study community surveillance. AMI was classified by physician review using a validated algorithm. Clinical data, medications, and procedures were abstracted from the medical record. Main study outcomes included short‐ and long‐term mortality within 28 days and 1 year of AMI hospitalization. Between 2000 and 2014, a total of 742 (3.6%) of 20 569 patients with AMI were identified with no documented SMuRFs. Patients without SMuRFs were less likely to receive aspirin, nonaspirin antiplatelet therapy, or beta blockers and less often underwent angiography and revascularization. Compared with those with one or more SMuRFs, patients without SMuRFs had significantly higher 28‐day (odds ratio, 3.23 [95% CI, 1.78–5.88]) and 1‐year (hazard ratio, 2.09 [95% CI, 1.29–3.37]) adjusted mortality. When examined across 5‐year intervals from 2000 to 2014, the incidence of 28‐day mortality significantly increased for patients without SMuRFs (7% to 15% to 27%), whereas it declined for those with 1 or more SMuRFs (7% to 5% to 5%). Conclusions: Individuals without SMuRFs presenting with AMI have an increased risk of all‐cause mortality with an overall lower prescription rate for guideline‐directed medical therapy. These findings highlight the need for evidence‐based pharmacotherapy during hospitalization and the need to discover new markers and mechanisms for early risk identification in this population.
- Open Access
- 18 May 2023
- Published by Elsevier in Journal of the Society for Cardiovascular Angiography & Interventions
- Vol. 2 (3) , 100707
A-43 | Influence of Hospital Location on Outcomes in ST-Segment Myocardial Infarction Among Patients Hospitalized for Non-Cardiac Indications
- 18 May 2023
- Published by Elsevier in Journal of the Society for Cardiovascular Angiography & Interventions
- Vol. 2 (3) , 100707
Open AccessA-43 | Influence of Hospital Location on Outcomes in ST-Segment Myocardial Infarction Among Patients Hospitalized for Non-Cardiac Indications
- Open Access
- 18 May 2023
- Published by Elsevier in Journal of the Society for Cardiovascular Angiography & Interventions
- Vol. 2 (3) , 100713
A-49 | Influence of Risk Factors on Outcomes in ST-Segment Myocardial Infarction Among Patients Hospitalized for Non-Cardiac Indications
- 18 May 2023
- Published by Elsevier in Journal of the Society for Cardiovascular Angiography & Interventions
- Vol. 2 (3) , 100713
Open AccessA-49 | Influence of Risk Factors on Outcomes in ST-Segment Myocardial Infarction Among Patients Hospitalized for Non-Cardiac Indications
- Open Access
- 18 May 2023
- Published by Elsevier in Journal of the Society for Cardiovascular Angiography & Interventions
- Vol. 2 (3) , 100688
A-24 | The Impact of Race on Outcomes in ST-Segment Elevation Myocardial Infarction Among Patients Hospitalized for Non-Cardiac Indications
- 18 May 2023
- Published by Elsevier in Journal of the Society for Cardiovascular Angiography & Interventions
- Vol. 2 (3) , 100688
Open AccessA-24 | The Impact of Race on Outcomes in ST-Segment Elevation Myocardial Infarction Among Patients Hospitalized for Non-Cardiac Indications
- 16 May 2023
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 12 (10) , e028923
Impact of Diabetes on Outcomes in Patients Hospitalized With Acute Myocardial Infarction: Insights From the Atherosclerosis Risk in Communities Study Community Surveillance
Background: Diabetes is associated with increased risk of acute myocardial infarction (AMI). The demographic trends, clinical presentation, management, and outcomes of patients with diabetes who are hospitalized with AMI have not been recently reported. Methods and Results: The ARIC (Atherosclerosis Risk in Communities) study conducted hospital surveillance of AMI in 4 US communities. AMI was classified by physician review using a validated algorithm. Medications and procedures were abstracted from the medical record. From 2000 to 2014, 21 094 weighted hospitalizations for AMI were sampled. The prevalence of diabetes steadily increased, from 35% to 41% to 43% ( P ‐trend<0.0001) across 2000 to 2004, 2005 to 2009, and 2010 to 2014, respectively. Patients with diabetes were older (61 versus 59 years of age), more often Black (44% versus 31%), and more commonly women (42% versus 34%). The burden of cardiovascular comorbidities was higher with diabetes and increased temporally. Patients with diabetes less often presented with ST‐segment elevation (9% versus 17%) or acute chest pain (72% versus 80%), and had higher mean GRACE (Global Registry of Acute Coronary Syndrome) score (123 versus 109), Thrombolysis in Myocardial Ischemia (TIMI) score (4.3 versus 4.0), and Killip class (1.9 versus 1.5). Patients with diabetes had a lower adjusted probability of receiving aspirin (relative probability, 0.95 [95% CI, 0.91–0.99]), nonaspirin antiplatelets (0.93 [95% CI, 0.86–0.99]), coronary angiography (0.85 [95% CI, 0.78–0.92]), and coronary revascularization (0.85 [95% CI, 0.76–0.92]). Diabetes was associated with a 52% higher hazard of all‐cause 1‐year mortality (hazard ratio, 1.52 [95% CI, 1.23–1.89]). Conclusions: Diabetes is associated with higher risk of death in patients hospitalized with AMI, highlighting the need for adherence to evidence‐based therapies in this high‐risk population.
- 16 May 2023
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 12 (10) , e028923
Impact of Diabetes on Outcomes in Patients Hospitalized With Acute Myocardial Infarction: Insights From the Atherosclerosis Risk in Communities Study Community Surveillance
Background: Diabetes is associated with increased risk of acute myocardial infarction (AMI). The demographic trends, clinical presentation, management, and outcomes of patients with diabetes who are hospitalized with AMI have not been recently reported. Methods and Results: The ARIC (Atherosclerosis Risk in Communities) study conducted hospital surveillance of AMI in 4 US communities. AMI was classified by physician review using a validated algorithm. Medications and procedures were abstracted from the medical record. From 2000 to 2014, 21 094 weighted hospitalizations for AMI were sampled. The prevalence of diabetes steadily increased, from 35% to 41% to 43% ( P ‐trend<0.0001) across 2000 to 2004, 2005 to 2009, and 2010 to 2014, respectively. Patients with diabetes were older (61 versus 59 years of age), more often Black (44% versus 31%), and more commonly women (42% versus 34%). The burden of cardiovascular comorbidities was higher with diabetes and increased temporally. Patients with diabetes less often presented with ST‐segment elevation (9% versus 17%) or acute chest pain (72% versus 80%), and had higher mean GRACE (Global Registry of Acute Coronary Syndrome) score (123 versus 109), Thrombolysis in Myocardial Ischemia (TIMI) score (4.3 versus 4.0), and Killip class (1.9 versus 1.5). Patients with diabetes had a lower adjusted probability of receiving aspirin (relative probability, 0.95 [95% CI, 0.91–0.99]), nonaspirin antiplatelets (0.93 [95% CI, 0.86–0.99]), coronary angiography (0.85 [95% CI, 0.78–0.92]), and coronary revascularization (0.85 [95% CI, 0.76–0.92]). Diabetes was associated with a 52% higher hazard of all‐cause 1‐year mortality (hazard ratio, 1.52 [95% CI, 1.23–1.89]). Conclusions: Diabetes is associated with higher risk of death in patients hospitalized with AMI, highlighting the need for adherence to evidence‐based therapies in this high‐risk population.
- Open Access
- 6 April 2023
- Published by Elsevier in JACC: Asia
- Vol. 3 (3) , 431-442
Clinical Profiles, Outcomes, and Sex Differences of Patients With STEMI
- 6 April 2023
- Published by Elsevier in JACC: Asia
- Vol. 3 (3) , 431-442
Open AccessClinical Profiles, Outcomes, and Sex Differences of Patients With STEMI
- 1 March 2023
- Published by Wolters Kluwer Health in Circulation: Heart Failure
- Vol. 16 (3) , 270-278
Epidemiology and Outcomes of Aortic Stenosis in Acute Decompensated Heart Failure: The ARIC Study
Background: Few studies characterize the epidemiology and outcomes of aortic stenosis (AS) in acute decompensated heart failure (ADHF). This study investigates the significance of AS in contemporary patients who have experienced an ADHF hospitalization. Methods: The ARIC study (Atherosclerosis Risk in Communities) surveilled ADHF hospitalizations for residents ≥55 years of age in 4 US communities. ADHF cases were stratified by left ventricular ejection fraction (LVEF). Demographic differences in AS burden and the association of varying AS severities with mortality were estimated using multivariable logistic regression. Results: From 2005 through 2014, there were 3597 (weighted n=16 692) ADHF hospitalizations of which 48.6% had an LVEF <50% and 51.4% an LVEF ≥50%. AS prevalence was 12.1% and 18.7% in those with an LVEF <50% and ≥50%, respectively. AS was less likely in Black than White patients regardless of LVEF: LVEF <50% (odds ratio [OR], 0.34 [95% CI, 0.28–0.42]); LVEF ≥50% (OR, 0.51 [95% CI, 0.44–0.59]). Higher AS severity was independently associated with 1-year mortality in both LVEF subgroups: LVEF <50% (OR, 1.16 [95% CI, 1.04–1.28]); LVEF ≥50% (OR, 1.40 [95% CI, 1.28–1.54]). Sensitivity analyses excluding severe AS patients detected that mild/moderate AS was independently associated with 1-year mortality in both LVEF subgroups: LVEF <50% (OR, 1.23 [95% CI, 1.02–1.47]); LVEF ≥50% (OR, 1.31 [95% CI, 1.14–1.51]). Conclusions: Among patients who have experienced an ADHF hospitalization, AS is prevalent and portends poor mortality outcomes. Notably, mild/moderate AS is independently associated with 1-year mortality in this high-risk population.
- 1 March 2023
- Published by Wolters Kluwer Health in Circulation: Heart Failure
- Vol. 16 (3) , 270-278
Epidemiology and Outcomes of Aortic Stenosis in Acute Decompensated Heart Failure: The ARIC Study
Background: Few studies characterize the epidemiology and outcomes of aortic stenosis (AS) in acute decompensated heart failure (ADHF). This study investigates the significance of AS in contemporary patients who have experienced an ADHF hospitalization. Methods: The ARIC study (Atherosclerosis Risk in Communities) surveilled ADHF hospitalizations for residents ≥55 years of age in 4 US communities. ADHF cases were stratified by left ventricular ejection fraction (LVEF). Demographic differences in AS burden and the association of varying AS severities with mortality were estimated using multivariable logistic regression. Results: From 2005 through 2014, there were 3597 (weighted n=16 692) ADHF hospitalizations of which 48.6% had an LVEF <50% and 51.4% an LVEF ≥50%. AS prevalence was 12.1% and 18.7% in those with an LVEF <50% and ≥50%, respectively. AS was less likely in Black than White patients regardless of LVEF: LVEF <50% (odds ratio [OR], 0.34 [95% CI, 0.28–0.42]); LVEF ≥50% (OR, 0.51 [95% CI, 0.44–0.59]). Higher AS severity was independently associated with 1-year mortality in both LVEF subgroups: LVEF <50% (OR, 1.16 [95% CI, 1.04–1.28]); LVEF ≥50% (OR, 1.40 [95% CI, 1.28–1.54]). Sensitivity analyses excluding severe AS patients detected that mild/moderate AS was independently associated with 1-year mortality in both LVEF subgroups: LVEF <50% (OR, 1.23 [95% CI, 1.02–1.47]); LVEF ≥50% (OR, 1.31 [95% CI, 1.14–1.51]). Conclusions: Among patients who have experienced an ADHF hospitalization, AS is prevalent and portends poor mortality outcomes. Notably, mild/moderate AS is independently associated with 1-year mortality in this high-risk population.
- 1 June 2022
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 28 (6) , 883-892
The Relationship Between Atrial Fibrillation, Mitral Regurgitation, and Heart Failure Subtype: The ARIC Study
- 1 June 2022
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 28 (6) , 883-892
The Relationship Between Atrial Fibrillation, Mitral Regurgitation, and Heart Failure Subtype: The ARIC Study
- 21 February 2022
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 15 (4) , S52-S53
CRT-600.08 Contemporary Trends of Utilization of VA-ECMO Support With and Without Impella or Intra-Aortic Balloon Pump for Cardiogenic Shock in the United States 2016 to 2018
- 21 February 2022
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 15 (4) , S52-S53
CRT-600.08 Contemporary Trends of Utilization of VA-ECMO Support With and Without Impella or Intra-Aortic Balloon Pump for Cardiogenic Shock in the United States 2016 to 2018